All
Improvement in CAR T-Cell Therapy Removes Severe Side Effects
April 24th 2019University of Southern California scientists have made an advancement in chimeric antigen receptor (CAR) T-cell therapy that seems to eliminate its severe side effects, making the treatment safer and potentially available in outpatient settings.
Thermo Fisher, Genovis Collaborate to Advance Characterization and Monitoring Methods
April 12th 2019The companies will join forces on a research project to develop end-to-end workflows for the preparation, characterization, and monitoring of biotherapeutics using liquid chromatography-mass spectrometry.